WuXi Biologics, a global company with leading open access biologics technology platforms, announced that it has acquired a Bayer manufacturing facility in Wuppertal, Germany, which has completed Pfizer China (Pfizer) manufacturing facilities in Hangzhou, China and the CMAB Biopharma Group (CMAB). As part of the acquisition agreement signed with Bayer in December 2020, WuXi Biologics…